WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences: 

• RBC Capital Markets Global Healthcare Conference, New York City, May 14 – 15, 2024
• B.Riley Securities 24^th Annual Institutional Investor Conference, Beverly Hills, May 22 – 23, 2024
• Stifel Cross Sector Insight Conference, Boston, June 4 – 5, 2024
• William Blair & Co. Annual Growth Stock Conference, Chicago, June 4 – 6, 2024
• The Citizens JMP Medical Devices and Healthcare Services Forum, Boston, June 20, 2024

Conference Details: 

To request a meeting or for more details about the conferences please reach out to your institutional contact.

About OptimizeRx 

OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 2 million U.S. healthcare providers and millions of their patients through an intelligent technology platform embedded within a proprietary digital point-of-care network, as well as mass digital communication channels, OptimizeRx helps life sciences organizations engage and support their customers.

For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.  

Important Cautions Regarding Forward Looking Statements 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans, and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.

OptimizeRx Contact  
Andy D’Silva, SVP Corporate Finance 
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Media Relations Contact  
Dilma Bennett, Media Relations Manager 
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Investor Relations Contact 
Ashley Robinson 
LifeSci Advisors, LLC 
This email address is being protected from spambots. You need JavaScript enabled to view it.